Bladder consensus conference committee. Am J Surg Pathol 1998, 22:1435–1448.PubMedCrossRef 3. Lee R, Droller MJ: The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 2000, 27:1–13. viiPubMedCrossRef 4. Said N, Theodorescu D: Pathways of metastasis suppression in bladder cancer. Cancer

Metastasis Rev 2009, 28:327–333.PubMedCrossRef 5. Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, et al.: Targeting EGFR in bladder cancer. World J Urol 2007, 25:573–579.PubMedCrossRef 6. Neal DE, Mellon K: Epidermal growth factor receptor and bladder cancer: a review. Urol Int 1992, 48:365–371.PubMedCrossRef 7. Selleck GS-4997 Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, et al.: Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. J Urol 2008, 179:353–358.PubMedCentralPubMedCrossRef 8. Witters L, Kumar R, Mandal M, Bennett CF, Miraglia GSK2399872A chemical structure L, et https://www.selleckchem.com/products/pexidartinib-plx3397.html al.: Antisense oligonucleotides to the epidermal growth factor receptor. Breast Cancer Res Treat 1999, 53:41–50.PubMedCrossRef 9. Bhuvaneswari R, Gan YY, Soo KC, Olivo M: Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Mol Cancer 2009, 8:94.PubMedCentralPubMedCrossRef 10. Nilsson J, Vallbo C, Guo D,

Golovleva I, Hallberg B, et al.: Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun 2001, 284:1155–1161.PubMedCrossRef 11. Holmlund C, Nilsson J, Guo D, Starefeldt A, Golovleva I, et al.: Characterization and tissue-specific expression of human LRIG2.

Gene 2004, 332:35–43.PubMedCrossRef 12. Guo D, Holmlund C, Henriksson R, Hedman H: The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 2004, 84:157–165.PubMedCrossRef 13. Gur G, Rubin C, Katz M, Amit I, Citri A, et al.: LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 2004, 23:3270–3281.PubMedCrossRef 14. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, et al.: The leucine-rich repeat Fludarabine mw protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem 2004, 279:47050–47056.PubMedCrossRef 15. Yang WM, Yan ZJ, Ye ZQ, Guo DS: LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87. BJU Int 2006, 98:898–902.PubMedCrossRef 16. Li F, Ye ZQ, Guo DS, Yang WM: Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1. Oncol Rep 2011, 26:439–446.PubMed 17. Goel S, Hidalgo M, Perez-Soler R: EGFR inhibitor-mediated apoptosis in solid tumors. J Exp Ther Oncol 2007, 6:305–320.PubMed 18. Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, et al.